A


Alunbrig™ (06-9-2017)

Class: Biological Therapy Generic Name: brigatinib (bri-GA-ti-nib) Trade Name: Alunbrig For which conditions is this drug approved? Brigatinib is used for patients with non-small cell lung cancer (NSCLC) with a certain type of abnormal anaplastic lymphoma... Continue Reading

avelumab (06-9-2017)

Class: Biological Therapy Generic Name: avelumab Trade Name: Bavencio® For which conditions is this drug approved? Bavencio is approved for patients with a certain type of skin cancer called Merkel cell carcinoma. It is also approved for patients... Continue Reading

Actemra® (06-9-2017)

Class: Biologic Therapy Generic Name: tocilizumab Trade Name: Actemra® How is this drug used? Actemra is approved for adults with moderate to severe rheumatoid arthritis (RA) when one or more other Disease Modifying Anti-Rheumatic Drugs (DMARDs) have... Continue Reading

anakinra (06-9-2017)

Class: Biologic Therapy Generic Name: anakinra Trade Name: Kineret® How is this drug used? Kineret is approved for adults to reduce the signs and symptoms and slow the damage of moderate to severe rheumatoid arthritis (RA) when one or more other drugs... Continue Reading

adalimumab-atto (10-5-2016)

Class: Biosimilar Generic Name: adalimumab-atto Trade Name: Amjevita For which conditions is this drug indicated? Amjevita is indicated for use in several types of arthritis: rheumatoid (RA), juvenile idiopathic (JIA), psoriatic (PsA), and ankylosing... Continue Reading

Amjevita™ (10-5-2016)

Class: Biosimilar Generic Name: adalimumab-atto Trade Name: Amjevita For which conditions is this drug indicated? Amjevita is indicated for use in several types of arthritis: rheumatoid (RA), juvenile idiopathic (JIA), psoriatic (PsA), and ankylosing... Continue Reading

atezolizumab (06-8-2016)

Class: Biological Therapy Generic Name: atezolizumab Trade Name: Tecentriq® How is this drug used? Tecentriq is approved for patients with metastatic non-small cell lung cancer (NSCLC) whose disease progressed during or following therapy with a platinum... Continue Reading

Alecensa® (01-14-2016)

Class: Biological Therapy Generic Name: alectinib Trade Name: Alecensa® For which conditions is this drug approved? Alecensa is approved to treat patients with non-small cell lung cancer (NSCLC) that has a mutation in the anaplastic lymphoma kinase... Continue Reading

alectinib (01-14-2016)

Class: Biological Therapy Generic Name: alectinib Trade Name: Alecensa® For which conditions is this drug approved? Alecensa is approved to treat patients with non-small cell lung cancer (NSCLC) that has a mutation in the anaplastic lymphoma kinase... Continue Reading

abatacept (01-12-2016)

Class: Immunotherapy Generic Name: abatacept Trade Name: Orencia® For which conditions is this drug approved? Orencia is approved for use in adults with moderate to severe rheumatoid arthritis (RA). This includes patients who have tried other medicines... Continue Reading

« Previous PageNext Page »